Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Luis Javier Marfil‐Rivera"'
Autor:
José Carlos Jaime-Pérez, Marcela Hernández-Coronado, José Antonio Hernández-De Los Santos, Luis Javier Marfil-Rivera, David Gómez-Almaguer
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 44, Iss 3, Pp 314-320 (2022)
Background: The date of acute lymphoblastic leukemia (ALL) diagnosis has been studied regarding potential etiologic roles with contrasting results and the issue remains controversial. The principal aim of this study was to analyze monthly variation o
Externí odkaz:
https://doaj.org/article/1cdd7f4250da45729b5eb125755dc07e
Autor:
José Carlos Jaime-Pérez, Gisela García-Arellano, José Luis Herrera-Garza, Luis Javier Marfil-Rivera, David Gómez-Almaguer
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 41, Iss 1, Pp 57-61 (2019)
Background: Heterogeneity regarding clinical and laboratory findings at diagnosis of acute lymphoblastic leukemia exists. The frequency of complete blood count abnormalities and its combinations, symptoms and physical findings were investigated in Hi
Externí odkaz:
https://doaj.org/article/dcfb97207bb34061a48f355742ebfea8
Autor:
José Carlos Jaime-Pérez, Adrián Chapa-Rodríguez, Marisol Rodríguez-Martínez, Perla Rocío Colunga-Pedraza, Luis Javier Marfil-Rivera, David Gómez-Almaguer
Publikováno v:
Revista Brasileira de Hematologia e Hemoterapia, Vol 34, Iss 2, Pp 103-108 (2012)
BACKGROUND: Complementary and alternative medicine includes a diverse group of medical and healthcare systems, practices and products not considered part of conventional medicine. Although there is information on unconventional practices in oncologic
Externí odkaz:
https://doaj.org/article/d3171f54810741c9be18c17e7abfe074
Autor:
Rodrigo Abensur Athanazio MD, PhD, José Manuel Ceresetto MD, Luis Javier Marfil Rivera MD, Gabriela Cesarman-Maus MD, PhD, Kenny Galvez MD, Marcos Arêas Marques MD, Aldo Hugo Tabares MD, Carlos Alberto Ortiz Santacruz MD, Fernando Costa Santini MD, Luis Corrales MD, Alexander T. Cohen MBBS, MSc, MD, FRACP, FESC
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 28 (2022)
Venous thromboembolism (VTE) is a leading cause of morbidity and mortality in patients with cancer. On the basis of results from randomized controlled trials, direct oral anticoagulants (DOACs) are now recommended for the treatment of cancer-associat
Externí odkaz:
https://doaj.org/article/8ab748bf4e814de590a626a9dc9e0e02
Autor:
José Carlos Jaime‐Pérez, Jesús D. Meléndez‐Flores, Eugenia M. Ramos‐Dávila, César Homero Gutiérrez‐Aguirre, Olga G. Cantú‐Rodríguez, Luis Javier Marfil‐Rivera, Jesús Áncer‐Rodríguez, David Gómez‐Almaguer
Publikováno v:
Clinical Transplantation.
Autor:
Carlos Acosta-Olivo, Rodolfo Morales-Avalos, Domingo Garay-Mendoza, Jessica K. Cerda-Barbosa, Ana María Espinoza-Galindo, Nancy L. Valdés-González, Félix Vilchez-Cavazos, Lourdes Garza-Ocañas, Víctor M. Peña-Martínez, Tomas Ramos-Morales, Luis Javier Marfil-Rivera
Publikováno v:
The Journal of Knee Surgery. 34:383-405
Total primary knee replacement results in significant postoperative bleeding. There are reports that 20 to 50% of the patients require a blood transfusion, which has been related to many complications, resulting in the search for strategies to reduce
Autor:
Martha A. Reyes-López, Karina Elizabeth Vázquez-Hernández, Luis A. González-Torres, Odra Martínez-González, Luz Tarín-Arzaga, Luis Javier Marfil-Rivera, David Gómez-Almaguer, Carlos de la Cruz-de la Cruz, Omar Cantú-Martínez
Publikováno v:
Medicina Universitaria, Vol 23, Iss 1 (2021)
Lupus anticoagulant (LA) is a heterogeneous group of antibodies that interfere with phospholipid-dependent coagulation tests, which result in abnormally prolonged clotting times in vitro. The prevalence of LA in a healthy individual is 1-5%1,2.
Autor:
José Carlos Jaime-Pérez, David Gómez-Almaguer, Lorena Salazar-Cavazos, Luis Javier Marfil-Rivera, Marcela Hernández-Coronado
Publikováno v:
Blood cells, moleculesdiseases. 88
Ambulatory allogeneic hematopoietic cell transplantation (allo-HCT) after reduced-intensity conditioning (RIC) is a cost-effective option for hematology patients. Data on the impact of transfusion burden in this setting are scarce; we analyzed this r
Autor:
Luis Javier Marfil-Rivera, Marcela Hernández-Coronado, José Antonio Hernández De los Santos, David Gómez-Almaguer, José Carlos Jaime-Pérez
Publikováno v:
Hematology, transfusion and cell therapy. 44(3)
The date of acute lymphoblastic leukemia (ALL) diagnosis has been studied regarding potential etiologic roles with contrasting results and the issue remains controversial. The principal aim of this study was to analyze monthly variation of ALL diagno
Autor:
Odila Saucedo-Cárdenas, Olivia A Robles-Rodríguez, Arnulfo Villanueva-Olivo, Laura Villarreal-Martínez, María de Jesús Loera-Arias, Roberto Montes de Oca-Luna, Aracely Garcia-Garcia, Luis Javier Marfil-Rivera, Humberto Rodriguez-Rocha, José J Pérez-Trujillo
Publikováno v:
Journal of Biosciences. 45
Hemophilia is a hereditary disorder that can be life-threatening in individuals who have severe spontaneous bleeding resulting from minor trauma or surgery. Although replacement therapy of the missing exogenous factor has improved patients' quality o